New vaccine shows 89% effectiveness in trials

A new vaccine, produced by Novavax is being welcomed after trials prove it's 89% effective against coronavirus. It’s also the first to show it works against the UK variant but is less effective against the South African one.

Meanwhile a row continues between the European Union and AstraZeneca over the supply and distribution of their vaccine on the continent. AstraZeneca says manufacturing problems at its European plants mean there will be a shortfall in doses for the EU.

US President, Joe Biden has immigration in his sights with executive orders which will overhaul the policies of the Trump Administration.